These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 6761899

  • 1. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T, Ohneda A, Nihei J, Kobayashi T.
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H, Kanazawa Y, Sando H, Hayashi M, Kawazu S, Kosaka K.
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [Abstract] [Full Text] [Related]

  • 4. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A, Kobayashi T, Nihei J.
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

  • 10. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT, Goulas S, Wollen N, McIntyre N.
    J Hepatol; 1998 Feb 15; 28(2):280-91. PubMed ID: 9514541
    [Abstract] [Full Text] [Related]

  • 11. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
    Hsieh SD, Kanazawa Y, Akanuma Y.
    Diabetes Res Clin Pract; 1985 Aug 15; 1(2):109-14. PubMed ID: 3915258
    [Abstract] [Full Text] [Related]

  • 12. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A, Matsuda K, Chiba M, Iimura Y, Yamagata S.
    Tohoku J Exp Med; 1975 Jun 15; 116(2):103-10. PubMed ID: 1154379
    [Abstract] [Full Text] [Related]

  • 13. Disappearance rate of endogenous human C-peptide from blood.
    Kuzuya T, Matsuda A.
    Diabetologia; 1976 Oct 15; 12(5):519-21. PubMed ID: 976639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
    Shimamura J, Taketa K, Ide T, Nakata K, Nagashima H.
    Acta Med Okayama; 1985 Oct 15; 39(5):385-96. PubMed ID: 3000142
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
    Costin G, Kogut MD, Hyman C, Ortega JA.
    Diabetes; 1977 Mar 15; 26(3):230-40. PubMed ID: 320076
    [Abstract] [Full Text] [Related]

  • 20. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
    Chiba M, Ohneda A, Sakai T, Goto Y.
    Tohoku J Exp Med; 1982 Feb 15; 136(2):169-75. PubMed ID: 7041329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.